Sentences with phrase «patients following disease»

Not exact matches

The main task of the ECS is to improve the quality of life of coeliac patients with following activities: protecting the interests of coeliac patients, informing the public about coeliac disease and glutenfree food and it's regulations, cooperation with medical staff, cooperation with food manufacturers and HoReCa, Crossed - Grain Symbol trademark licensing in Estonia, finding new opportunities for glutenfree products, dissemination of coeliac information, organising training courses, cooperation with other social organisations.

Patients with coeliac disease who have ongoing GI symptoms despite following a strict gluten free diet

Methods: This randomized, double - blind, placebo - controlled, prospective follow - up study involved 90 coeliac disease patients in remission randomized to consume glucose syrups, maltodextrins or placebo for 24 weeks.

He cites a study which showed that patients with ADHD and celiac disease experienced significant improvement after following a gluten free diet for six months.

The work was on the role of interleukin - 1 in the pathology of graft - versus - host disease (GVHD), the mechanism by which the new immune system, which a patient receives as a bone marrow transplant, attacks the patient's body following the transplantation.

The method can become useful to identify patients at risk of developing acute cardiovascular diseases, but also to follow up after surgery where plaque has already been removed.

Only about 7 percent of patients survive for five years following diagnosis of the disease.

Patients were followed every eight weeks until disease progression.

Written by Institute Associate Sonia L. Canzater, JD, MPH and Jeffrey S. Crowley, MPH, program director of infectious disease initiatives and distinguished scholar at the O'Neill Institute, the report was developed following an expert consultation held in Washington, DC, in September 2016 with diverse stakeholders, including hepatitis C medical and non-medical providers, patient advocates, epidemiologists, and federal hepatitis C policy and program staff.

The highest risk of death was seen among patients with multiple system atrophy with parkinsonism, followed by patients with dementia with Lewy bodies, Parkinson disease dementia and Parkinson disease, according to the results.

Through a prospective study using 4,798 patients, they showed that their PWV measurement was significantly associated with the onset of cardiovascular diseases over a ten - year follow up period.

In the next phase of the study, researchers will genetically sequence tumor cells from at least 500 patients and follow the course of their disease.

However, in the largest study of its kind so far, scientists from the German Cancer Research Center (DKFZ) in Heidelberg have now shown that the risk of death from heart disease in breast cancer patients following radiotherapy or chemotherapy is no higher than it is among the average population.

The benefit of chemotherapy, in addition to craniospinal radiation, was seen in adult patients with medulloblastoma (MB), including those with localized disease who received high - dose radiation treatment following surgery.

Patients with multiple illnesses such as heart disease, kidney disease and dementia, and rural residency were less likely than others to receive follow - up care in the following month.

The study results show that with a median (midpoint) follow - up of 20 months, 232 patients (75 percent) remained on therapy, 31 (10 percent) discontinued because of disease progression and 45 discontinued for other reasons (including 28 because of infection, eight for other adverse events and nine due to other medical events).

Eight of nine patients who are evaluable for response had no evidence of disease in their bone marrow at three months, and all remain in remission after a median follow - up period of six months, with a range from 0.5 to 9 months.

Desgrosellier said the team will follow up with mouse models containing tumor fragments from patients to better reflect the diversity of cell types present in human disease.

In the largest study of its kind, the researchers studied the long - term recovery (an average of 15 months) of 51 patients with Lyme disease - associated facial paralysis who sought follow - up care in the Facial Nerve Center at Mass..

The researchers now want to conduct follow - up studies to optimise the use of IgEnio — currently patients have to have IgE antibodies removed from their blood for a morning approximately once a week during the pollen season — and to test its use for treating inflammatory skin diseases, in which IgE antibodies are also implicated.

The report suggests that patients may benefit from additional assurances from clinical staff regarding; success rates in halting disease progression with anti-VEGF therapy, how it can reduce the risk of becoming blind in the future, and the low likelihood of serious problems occurring following the injections.

Following first - line treatment, patients experiencing disease progression were randomised 1:1 to receive second - line treatment of FOLFOX plus cetuximab (Arm A; n = 74) or sole FOLFOX (Arm B; n = 79).

«The biomarkers provide new plasma or serum tests to follow disease progression in our patients.»

Using the scale as a benchmark, patients without a history of chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease, or cirrhosis have only a 3.1 percent probability of developing late, serious complications following joint replacement surgery.

Currently, the only known and effective treatment for the disease is for patients to follow a gluten - free diet for the rest of their lives.

Other top findings from the report outline several successes in heart disease care as well as opportunities for further improving a patient's treatment and follow - up care experience.

«Patients with chronic kidney disease need to be aware of the potential for higher potassium content in sodium - reduced foods, as they are educated to follow a low sodium diet and may inadvertently choose sodium - reduced foods without realizing the risk of an increased potassium load from additives,» she said.

This student was able to spend one half - day a week in the city AIDS clinic to accommodate her interest in infectious diseases and to follow patients with tuberculosis infections.

• Fifty - eight percent of patients did not have regular follow - up eye exams • Smokers were 20 percent less likely to have exams • Those with less - severe disease and no eye problems were least likely to follow recommendations • Those who had diabetic retinopathy were 30 percent more likely to have follow - up exams

Prostate cancer patients whose tumour cells have high levels of this molecule are more than twice as likely to see their disease return following surgery.

For this study, the researchers used data from a population of patients with both diabetes and chronic kidney disease (stage 3 and 4) enrolled in follow up studies conducted by Dr. Krolewski and his team at the Joslin Diabetes Center and followed for four to 15 years.

A follow - up study of 96 other patients with Alzheimer's disease confirmed that this HLA variant is associated with earlier onset of Alzheimer's, although Payami cautions that another gene very close to HLA - A2, and not HLA - A2 itself, could be at fault.

Significant anti-tumor activity was observed as well: nearly 70 percent had a near complete or complete response within three months post treatment, which compares favorably with the expected responses (less than 40 percent) in patients without high - risk disease following an ASCT.

The patients were followed up through provincial health administrative data (Ontario, Canada) until May 2011 for CV disease (myocardial infarction, stroke, congestive heart failure, revascularization procedures) and death from any cause, analyzed as a composite outcome.

The team from the Arthritis Research UK Centre for Epidemiology looked at data from over 15,000 patients diagnosed with the disease who were being treated with certain types of immunosuppressive drugs, and found that one in five patients received no influenza vaccinations and one in two patients received no pneumonia vaccine over a five year follow - up period.

Appearing in Lancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow - up show that 5 - FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)- radiotherapy for patients with cT3 - resectable T4 M0 rectal cancer does not improve survival or disease - free survival.

While no clinical benefit could be definitively determined from the study, one patient did achieve stable disease at the 18 - month follow up, a response that remains today, following infusion of CART - EGFRvIII.

The study showed that patients who held their breath during radiation therapy had only a 1.4 percent rate of ischemic heart disease after 8 years of follow up and an estimated rate of 3.6 percent after 10 years.

Timothy L. Smith, M.D., M.P.H., of Oregon Health & Science University, Portland, and colleagues investigated the impact of comorbid obstructive sleep apnea (OSA) on CRS disease - specific QOL and sleep dysfunction in patients with CRS following functional endoscopic sinus surgery (FESS).

Following FESS, substantial gains in QOL and disease severity were observed for patients with CRS with and without OSA, and these gains were statistically significant.

In 2013, Virginia passed a Lyme Disease Testing Disclosure Act requiring physicians to inform patients that a negative Lyme test does not necessarily mean they are Lyme - free, and Maryland followed suit in 2016 with a similar law.

Called stereotactic body radiotherapy (SBRT), the study finds patients lived, on average, six to seven months longer following treatment with minimal side - effects even when they had other severe comorbidities such as chronic obstructive pulmonary disease (COPD), heart disease and diabetes.

After controlling for severity of disease and surgical complexity, analyses showed that the rate of unplanned 30 - day readmissions was approximately 78 percent for patients with any complication diagnosed following discharge from the hospital.

During a median follow - up of seven months, 20,152 patients (70.7 percent) required long - term dialysis and 5,696 (20 percent) died before progressing to ESRD (end - stage renal disease).

«Cancer patients need to have good primary care and cardiology follow - up to make sure all of their risk factors for heart disease are optimally controlled.

«This study allowed us to look more closely at the long - term outcomes of patients in whom the localized cancer in the prostate was successfully eradicated and compare them to patients whose disease persisted within the prostate following treatment,» adds Dr. Krauss.

Using cutting edge «disease in a dish» technologies, the researchers are now following up the leads discovered in blood cell lines in neurons induced from stem cells derived from the blood of PMDD patients — in hopes of gaining a more direct window into the ESC / E (Z) complex's role in the brain.

«For patients with advanced hepatitis C liver disease, liver transplants offer a second chance,» continued Professor Burra, «and for those who continue to suffer post-surgery, it's important for us to keep following up all avenues possible to improve their quality of life.»

However, the researchers stress that absolute risks are low — corresponding to one extra case of cancer for every 556 patients with inflammatory bowel disease followed for a year, compared with healthy individuals.

Most patients with multiple sclerosis have a type of the disease that has flare - ups, known as relapses, followed by an improvement in symptoms.